CClinicalTrials.gg
Active, not recruitingNCT06645080Updated Apr 29, 2026

Vision Screening in Hospitals for Older Adults Following a Fall

An observational study in Falls and Vision; Disorder, Loss, sponsored by University of Nottingham. Active, not recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-29.

Sponsored by University of Nottingham · Observational

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
105
Ages
18 Years and older
Sex
All
01

Study summary

Aims

This study aims to improve the way vision is checked and sight loss treated in older adults (65 years or older), who attend hospital following a fall.

Background

Falling is common in older adults. As the number of older people grows, the number of falls is expected to increase as well. Falling can affect a person's life in several ways: it can lead to pain, injuries, difficulty doing normal daily activities, weaker muscles, feeling isolated, losing independence and confidence, living in fear of falling, depression, difficulty in recovering from illnesses, developing other health problems more easily and a higher risk of death. Falls are a major health problem for the public and the United Kingdom (UK) spends more than £2 billion per year on caring for older adults who fall.

Problems with eyesight are also more common in older age and can have a similar effect on a person's independence, happiness and almost doubles their chances of falling. Sight loss in older age that is linked to falling is often treatable.

UK guidelines have been made to help prevent falls. These guidelines recommend checking for and treating sight loss in all older adults who attend hospital following a fall. However, this is only being done in a small number of hospitals. The reasons for this need to be investigated, in order to encourage and make it easier for health professionals to follow these guidelines.

Research has also shown that older adults, may be less likely to get their eyes tested regularly and attend hospital eye appointments. There are many reasons for this and vision screening whilst the patient is already receiving care in hospital, may be a good opportunity to address these issues. The views of the public are important for developing screening services that they understand and meets their needs. This study will gather the views of older people and their carers on hospital vision screening after a fall and the importance of looking after their eyes.

This study aims to improve the way vision is checked in older adults who attend hospital following a fall. This will help to identify and treat sight loss that may contribute to repeated falling. The study will combine the views of older adults and health professionals, to ensure that changes made meet patients' needs and are sustainable.

Design and methods

This study will have three parts:

  1. Focus groups asking health professionals about checking vision in patients who have fallen.
  2. Focus groups asking patients who have fallen and their carers about looking after their eyes.
  3. Development of a way of checking vision and treating sight loss in older adults who attend hospital following a fall.
02

Conditions studied

  • Falls
  • Vision; Disorder, Loss

Keywords

  • Falls
  • Vision screening
  • Intervention for falls prevention
  • Vision; Disorder, Loss
03

In context

Lead sponsor

University of Nottingham is the lead sponsor of 455 studies on the registry; 77 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Part one- Focus group study (with healthcare professionals):

Members of the acute multidisciplinary team who care for falls patients at Nottingham University Hospitals NHS Trust (NUHT) will be recruited.

Part two- Focus group study (with service users/ carers):

Current patients of NUHT or others recruited from the public, aged 65 or over who have had a fall. Carers of people aged 65 or over who have had a fall.

Part three- Intervention development using Delphi study:

Professionals with relevant knowledge and experience of falls assessments and management in hospitals for older people or the assessment and management of impaired vision in older people.

Inclusion criteria

Part one- Focus group study (with healthcare professionals):

  • Aged 18 years or above
  • Health professionals at NUHT
  • Must be involved in falls assessments/ management/ care of older falls patients as part of current/ previous role at NUHT.

Part two- Focus group study (with service users/ carers):

  • Adults ≥65 years
  • Had at least 1 fall requiring attendance at an emergency department
  • Carers of adults ≥65 who have had at least 1 fall requiring attendance at an emergency department

Part three- Intervention development using Delphi study:

  • Aged 18 years or above
  • Knowledge and experience of falls assessments and management in hospitals for older people
  • Experience of the assessment and management of impaired vision in older people

Exclusion criteria

Exclusion Criteria:

  • Those who are unable to give voluntary informed consent.
  • Those who have not sought secondary care following a fall.
05

Study design

Observational model
Other
Time perspective
Other
Enrollment
105 participants (estimated)
Patient registry
No

Groups and cohorts

  • Focus Group participants (health professionals)

    Other: Focus group or interview participation

  • Focus group participants (service users/ carers)

    Other: Focus group or interview participation

  • Delphi study participants

    Other: Delphi survey participation

Interventions

  • OtherFocus group or interview participation

    90 minute focus group or 60 minute interview participation

  • OtherDelphi survey participation

    Participation in a modified two-round Delphi technique. Optional third round in the event of insufficient agreement in the second round.

06

What researchers measure

Primary outcomes

  1. Percentage agreement on Delphi survey components

    After each complete Delphi round, the percentage agreement of responses for each survey component will be calculated to help decide upon the subsequent Delphi survey items to be included. Or, if in the case of the final survey round, to help decide if a further round is required in the event of disagreement.

    Time frame: Within 2 weeks of all Delphi round responses collected.

07

Study locations

1 site
  • Nottingham University Hospitals NHS Trust
    Nottingham, England NG7 2UH, United Kingdom
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06645080
Lead sponsor
University of Nottingham
Collaborators
Nottingham University Hospitals NHS Trust, The Dunhill Medical Trust
Responsible party
Sponsor
First posted
Oct 16, 2024
Start date
Feb 1, 2025
Primary completion
Sep 2026 (estimated)
Completion
Jun 2027 (estimated)
Last update
Apr 29, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion